What is CDXC's gross margin?

ChromaDex (CDXC) has a gross margin of 65% and a net margin of 3%.

What is CDXC's P/E ratio?

CDXC's P/E ratio is 39.4 with ROE of 22%.

Where can I see CDXC's full financials?

See ChromaDex (CDXC) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

ChromaDex (CDXC) Financials — Revenue, Earnings, Cash Flow

$7.87

Last traded 2025-04-14 — delisted

NASDAQ · Healthcare · Biotechnology · $611.9M mcap · 51M float · 1.59% daily turnover · Short 36% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$30M

Revenue

-65.0% YoY

$16M

Net Income

-9.8% YoY

$35M

Free Cash Flow

+67.8% YoY

64.8%

Gross Margin

2.4%

Op. Margin

3.2%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE21.8%

ROA16.1%

ROIC54.9%

Valuation

P/E39.4

P/B0.0

EV/EBITDA-7.7

Leverage

Debt/Equity0.03

Current Ratio6.50

Interest Cov.0.0x

Quality Scores

Piotroski F6/9

Altman Z-0.66

Beneish M0.00